GlassScriptPhysician profile
Patrina V Yao
NPI 1578719639
$1,200.72
in general payments reported to CMS, 2019-2025
20 companies · $16.74 in 2025
The $16.74 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $124 · 2020: $219 · 2021: $252 · 2022: $211 · 2023: $243 · 2024: $134 · 2025: $16.74.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $394.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $393.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $422.97 | 2021-2025 | Qulipta, Ubrelvy |
| Davol INC. | $154.79 | 2021 | |
| Lilly USA, LLC | $98.57 | 2024 | Kisunla |
| E.R. Squibb & Sons, L.L.C. | $58.26 | 2020-2021 | |
| Allergan, INC. | $56.44 | 2020-2021 | |
| Ucb, INC. | $45.39 | 2019-2020 | |
| Lundbeck LLC | $43.79 | 2022-2023 | Rexulti |
| Amneal Pharmaceuticals LLC | $39.46 | 2019-2020 | |
| Alexion Pharmaceuticals, INC. | $37.84 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $36.61 | 2021 | |
| Novartis Pharmaceuticals Corporation | $35.83 | 2019-2020 | |
| Biogen, INC. | $33.45 | 2020 | |
| Sk Life Science, INC. | $27.50 | 2020 | |
| Argenx US, INC. | $23.00 | 2022 | |
| Eisai INC. | $17.24 | 2023 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $16.05 | 2020 | |
| Horizon Therapeutics Plc | $14.28 | 2023 | Uplizna |
| Avanir Pharmaceuticals, INC. | $13.57 | 2019 | |
| Supernus Pharmaceuticals, INC. | $13.45 | 2019 | |
| Biohaven Pharmaceutical Holding Company LTD. | $12.23 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrina Yao listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.